Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mediators Inflamm ; 2022: 7641357, 2022.
Article in English | MEDLINE | ID: mdl-35069009

ABSTRACT

The objective of this study was to evaluate the histopathological changes caused by infection with the Colombian strain of Trypanosoma cruzi (T. cruzi) in the acute and chronic experimental phases. C57Bl/6 mice were infected with 1000 trypomastigote forms of the Colombian strain of T. cruzi. After 30 days (acute phase) and 90 days (early chronic phase) of infection, the animals were euthanized, and the colon was collected and divided into two parts: proximal and distal. The distal portion was used for histopathological analysis, whereas the proximal portion was used for quantification of pro- and anti-inflammatory cytokines. In addition, the weight of the animals and parasitemia were assessed. The infection induced gradual weight loss in the animals. In addition, the infection induced an increase in interferon gamma (IFNγ) and tumor necrosis factor-alpha (TNF-α) in the intestine in the acute phase, in which this increase continued until the early chronic phase. The same was observed in relation to the presence of intestinal inflammatory infiltrates. In relation to interleukin (IL)-10, there was an increase only in the early chronic phase. The Colombian strain infection was also able to induce neuronal loss in the myenteric plexus and deposition of the collagen fibers during the acute phase. The Colombian strain of T. cruzi is capable of causing histopathological changes in the intestine of infected mice, especially in inducing neuronal destructions. Thus, this strain can also be used to study the intestinal form of Chagas disease in experimental models.


Subject(s)
Chagas Disease , Trypanosoma cruzi , Animals , Collagen , Colombia , Intestines/pathology , Mice , Mice, Inbred C57BL
2.
J Immunol Res ; 2021: 6668739, 2021.
Article in English | MEDLINE | ID: mdl-33928170

ABSTRACT

The association between inflammatory processes and intestinal neuronal destruction during the progression of Chagasic megacolon is well established. However, many other components play essential roles, both in the long-term progression and control of the clinical status of patients infected with Trypanosoma cruzi. Components such as neuronal subpopulations, enteric glial cells, mast cells and their proteases, and homeostasis-related proteins from several organic systems (serotonin and galectins) are differentially involved in the progression of Chagasic megacolon. This review is aimed at revealing the characteristics of the intestinal microenvironment found in Chagasic megacolon by using different types of already used biomarkers. Information regarding these components may provide new therapeutic alternatives and improve the understanding of the association between T. cruzi infection and immune, endocrine, and neurological system changes.


Subject(s)
Biomarkers/metabolism , Chagas Disease/diagnosis , Inflammation/diagnosis , Megacolon/diagnosis , Trypanosoma cruzi/physiology , Animals , Cellular Microenvironment , Chagas Disease/immunology , Endocrine System , Humans , Immune System , Inflammation/immunology , Megacolon/immunology , Nervous System , Neuroimmunomodulation
3.
Vaccine ; 27(31): 4219-24, 2009 Jun 24.
Article in English | MEDLINE | ID: mdl-19393709

ABSTRACT

The world production capacity of influenza vaccines is a concern in face of the potential influenza pandemic. The use of adjuvants could increase several fold the current installed production capacity. Bordetella pertussis monophosphyl lipid A (MPLA) was produced by acid hydrolysis of LPS, obtained as a by-product of its removal from cellular pertussis vaccine, generating a product with 4 side chains. We have investigated different formulations including MPLA alone or combined with Al(OH)(3) as adjuvants for an inactivated split virion influenza vaccine. Our results demonstrate that MPLA at concentrations as low as 0.01 microg per dose of vaccine is effective, even with a 4-fold reduction of the regular vaccine dose, as measured by the induction of protective hemagglutination inhibition (HAI) titers. Al(OH)(3) can be combined with 0.01-10 microg MPLA, inducing even higher immune responses. Al(OH)(3) caused a drift of the immune response induced by the vaccine towards a Th2 profile, as evaluated by an increase in the IgG1:IgG2a ratio, while MPLA showed a more balanced response. Moreover, the use of MPLA and Al(OH)(3) combination led to the induction of the highest IgG levels together with the secretion of both IFN-gamma and IL-4. Although cell-mediated immune responses have not been usually taken into account for influenza vaccine formulations, they may be relevant for the induction of cross-protection as well as immunological memory for both inter-pandemic and pandemic influenza vaccines. Our results indicate that a more favorable profile of both humoral and cell-mediated immune responses may be obtained using the MPLA/Al(OH)(3) formulation.


Subject(s)
Adjuvants, Immunologic/pharmacology , Bordetella pertussis/chemistry , Influenza Vaccines/immunology , Lipid A/analogs & derivatives , Adjuvants, Immunologic/isolation & purification , Aluminum Hydroxide/pharmacology , Animals , Antibodies, Viral/blood , Hemagglutination Inhibition Tests , Immunoglobulin G/blood , Interferon-gamma/metabolism , Interleukin-4/metabolism , Lipid A/isolation & purification , Lipid A/pharmacology , Mice , Mice, Inbred BALB C , Vaccines, Subunit/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...